Beyond BRCA: Exploring PARP Combinations in Prostate Cancer

Hear from the experts on how the latest clinical data from ASCO GU 2021 inform leveraging PARP inhibitor&ndash based combinations for treating prostate cancer with and without DNA damage repair alterations. Review their insights in clinical commentaries along with slides a podcast and on-demand Webcast adapted from a live CCO Webinar.

Share

Program Content

No activities added yet

Activities

Other PARPi Combos in mCRPC
PARP Inhibitor Combinations in Prostate Cancer: Immune Checkpoint Inhibitors and Other Agents
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 19, 2021

Expires: February 18, 2022

Single Agent PARPi in mCRPC
Single-Agent PARP Inhibitors in Advanced Prostate Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 19, 2021

Expires: February 18, 2022

PARPi + ARi in mCRPC
PARP Combinations in Prostate Cancer: PARPi Plus Androgen Receptor Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 19, 2021

Expires: February 18, 2022

<i>EP</i>: PARPi Combos in PCa
ExpressPoints
Beyond BRCA: Exploring PARP Combinations in Prostate Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 03, 2021

Expires: March 02, 2022

Activities

PARPi Beyond mCRPC
PARP Inhibitors in Settings Beyond Metastatic Castration-Resistant Prostate Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 02, 2021

Expires: April 01, 2022

Activities

Podcast Pearls: Prostate Cancer PARPi
Podcast Pearls: Expert Answers to Questions on PARP Inhibition for Prostate Cancer
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: April 06, 2021

Expires: April 05, 2022

Prostate Cancer PARPi Q&A
Expert Answers to Questions on PARP Inhibition for Prostate Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: April 06, 2021

Expires: April 05, 2022

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer TEXT Only